MAR 31, 2021 9:36 AM PDT

Understanding the risk of thrombosis for cancer patients

New research from the Comprehensive Cancer Center (CCC) of Medical University of Vienna and Vienna General Hospital suggests that patients with cancer treated with immune checkpoint inhibitors are at substantial risk of developing venous and arterial thromboembolism (VTE/ATE). The retrospective study, conducted with data from cancer patients treated with immune checkpoint inhibitors from 2015 to 2018, focused on patients with melanoma and non-small cell lung cancer. The study’s findings are published in the journal Blood

"Patients who are treated with immune checkpoint inhibitors have often had previous cancer treatment and, in most cases, have advanced cancers. We might therefore expect a significant risk of thromboembolism but, so far, the large-scale treatment studies conducted for immune checkpoint inhibitors have not reported on it," says Principal Investigator Cihan Ay.

In exploring the clinical impact of immune checkpoint inhibitor treatment, the team found that VTE under immune checkpoint inhibitors strongly impairs clinical outcomes and is associated with increased mortality. "The cumulative incidence of venous thromboembolism was 12.9% and of arterial thromboses 1.8%. This risk appears to be independent of the underlying type of cancer and the immune checkpoint inhibitor used since similar rates of thrombosis were observed in these subgroups," explains study author Florian Moik. 

Additionally, they determined not only that VTE is quite challenging to predict, but also that it is associated with a shorter time before tumor progression and could cause delays or discontinuation of treatment altogether.  

"The results underscore the negative impact of venous and arterial thromboembolism on the clinical course of cancer patients," says study author  Florian Moik. "This study fails to determine whether the high risk of thromboembolism that has been observed has a causal link with immune-checkpoint-inhibitor therapy or merely reflects the underlying basic risk in this patient group." Irrespective of this, he believes it is important to build awareness of these complications, particularly in the light of the high efficacy of this new cancer treatment. "This paper, therefore, serves as a basis for future studies with a view to identifying patients who could benefit from thrombosis prophylaxis, especially to prevent venous thromboembolism."

Sources: Blood, Eureka Alert

About the Author
BA Environmental Studies
Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
AUG 25, 2022
Cancer
Nearly Half of Global Cancer Deaths Attributed to Behavioral Risk Factors
AUG 25, 2022
Nearly Half of Global Cancer Deaths Attributed to Behavioral Risk Factors
Cancer is a broad description of various related diseases resulting from abnormal and excessive cell growth.  While ...
SEP 15, 2022
Immunology
How a Cancer-Causing Virus Evades Human Immunity
SEP 15, 2022
How a Cancer-Causing Virus Evades Human Immunity
While our immune system is usually able to identify and destroy pathogenic invaders like bacteria and viruses, those mic ...
SEP 13, 2022
Health & Medicine
Mesothelioma: What Is it and What can Patients Diagnosed With it Do to Improve Quality of Life
SEP 13, 2022
Mesothelioma: What Is it and What can Patients Diagnosed With it Do to Improve Quality of Life
A 2022 Centers for Diseases Control and Prevention (CDC) report showed only 2,385 mesothelioma cases in the United State ...
OCT 13, 2022
Cancer
A Fungus Among Cancers
OCT 13, 2022
A Fungus Among Cancers
The cancer microbiome, the collection of microorganisms, including bacteria, viruses, and fungi, that live in or around ...
NOV 07, 2022
Cancer
Compound Produced by Pomegranates Could Help Fight Cancer
NOV 07, 2022
Compound Produced by Pomegranates Could Help Fight Cancer
Since ancient times, scientific and anecdotal evidence has noted many health benefits associated with pomegranates prope ...
NOV 15, 2022
Genetics & Genomics
Revealing the Mutations that Make Melanoma Immortal
NOV 15, 2022
Revealing the Mutations that Make Melanoma Immortal
Telomeres cap the ends of chromosomes, preventing breakage. Some cancer cells can use those protective caps to their adv ...
Loading Comments...